Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
CNY 7.04
(-1.4%)
CNY 7.04
(-1.4%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 853.66 Million CNY | 0.74% |
| 2022 | 830.04 Million CNY | -5.45% |
| 2021 | 877.92 Million CNY | 4.19% |
| 2020 | 842.58 Million CNY | -16.8% |
| 2019 | 1.01 Billion CNY | 3.86% |
| 2018 | 975.08 Million CNY | -5.74% |
| 2017 | 1.03 Billion CNY | 10.16% |
| 2016 | 939.01 Million CNY | 14.57% |
| 2015 | 819.59 Million CNY | 4.02% |
| 2014 | 787.89 Million CNY | 22.36% |
| 2013 | 643.89 Million CNY | 7.23% |
| 2012 | 600.5 Million CNY | 13.53% |
| 2011 | 528.92 Million CNY | 2.46% |
| 2010 | 516.22 Million CNY | 24.43% |
| 2009 | 414.88 Million CNY | 33.08% |
| 2008 | 311.75 Million CNY | 16.4% |
| 2007 | 267.83 Million CNY | 18.32% |
| 2006 | 226.37 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 143.75 Million CNY | -28.26% |
| 2024 Q1 | 200.38 Million CNY | 0.81% |
| 2024 Q3 | 157.71 Million CNY | 9.71% |
| 2023 Q4 | 198.78 Million CNY | 9.39% |
| 2023 Q2 | 218.45 Million CNY | -12.96% |
| 2023 Q1 | 250.97 Million CNY | 21.18% |
| 2023 FY | 836.2 Million CNY | 0.74% |
| 2023 Q3 | 181.72 Million CNY | -16.82% |
| 2022 Q3 | 194.52 Million CNY | -4.11% |
| 2022 Q1 | 225.54 Million CNY | 10.35% |
| 2022 FY | 830.04 Million CNY | -5.45% |
| 2022 Q4 | 207.1 Million CNY | 6.47% |
| 2022 Q2 | 202.86 Million CNY | -10.05% |
| 2021 FY | 877.92 Million CNY | 4.19% |
| 2021 Q1 | 229.09 Million CNY | 0.23% |
| 2021 Q2 | 225.78 Million CNY | -1.45% |
| 2021 Q3 | 218.65 Million CNY | -3.16% |
| 2021 Q4 | 204.38 Million CNY | -6.53% |
| 2020 Q3 | 217.12 Million CNY | 10.5% |
| 2020 Q2 | 196.48 Million CNY | -1.96% |
| 2020 Q1 | 200.41 Million CNY | -24.91% |
| 2020 FY | 842.58 Million CNY | -16.8% |
| 2020 Q4 | 228.57 Million CNY | 5.27% |
| 2019 Q2 | 260.61 Million CNY | 6.51% |
| 2019 FY | 1.01 Billion CNY | 3.86% |
| 2019 Q4 | 266.89 Million CNY | 10.95% |
| 2019 Q3 | 240.54 Million CNY | -7.7% |
| 2019 Q1 | 244.68 Million CNY | 8.74% |
| 2018 Q2 | 266.21 Million CNY | 3.49% |
| 2018 Q1 | 257.25 Million CNY | -10.35% |
| 2018 FY | 975.08 Million CNY | -5.74% |
| 2018 Q4 | 225.02 Million CNY | -0.69% |
| 2018 Q3 | 226.59 Million CNY | -14.89% |
| 2017 Q2 | 265.36 Million CNY | 17.28% |
| 2017 FY | 1.03 Billion CNY | 10.16% |
| 2017 Q4 | 286.94 Million CNY | 12.15% |
| 2017 Q3 | 255.85 Million CNY | -3.58% |
| 2017 Q1 | 226.27 Million CNY | -12.69% |
| 2016 Q1 | 207.25 Million CNY | 56.33% |
| 2016 FY | 939.01 Million CNY | 14.57% |
| 2016 Q4 | 259.16 Million CNY | 11.17% |
| 2016 Q2 | 239.46 Million CNY | 15.54% |
| 2016 Q3 | 233.12 Million CNY | -2.65% |
| 2015 Q2 | 275.13 Million CNY | 52.33% |
| 2015 Q4 | 132.57 Million CNY | -42.68% |
| 2015 Q3 | 231.26 Million CNY | -15.94% |
| 2015 FY | 819.59 Million CNY | 4.02% |
| 2015 Q1 | 180.62 Million CNY | -31.32% |
| 2014 Q1 | 171.8 Million CNY | 2.38% |
| 2014 Q2 | 169.09 Million CNY | -1.58% |
| 2014 Q4 | 262.99 Million CNY | 42.94% |
| 2014 FY | 787.89 Million CNY | 22.36% |
| 2014 Q3 | 183.99 Million CNY | 8.81% |
| 2013 Q1 | 141.87 Million CNY | -9.46% |
| 2013 Q2 | 171.07 Million CNY | 20.58% |
| 2013 Q3 | 163.13 Million CNY | -4.64% |
| 2013 Q4 | 167.81 Million CNY | 2.87% |
| 2013 FY | 643.89 Million CNY | 7.23% |
| 2012 FY | 600.5 Million CNY | 13.53% |
| 2012 Q4 | 156.7 Million CNY | -3.69% |
| 2012 Q2 | 158.66 Million CNY | 29.6% |
| 2012 Q3 | 162.71 Million CNY | 2.55% |
| 2012 Q1 | 122.42 Million CNY | -26.01% |
| 2011 Q3 | 96.78 Million CNY | -35.69% |
| 2011 FY | 528.92 Million CNY | 2.46% |
| 2011 Q4 | 165.45 Million CNY | 70.95% |
| 2011 Q1 | 116.17 Million CNY | -38.74% |
| 2011 Q2 | 150.5 Million CNY | 29.56% |
| 2010 Q3 | 106.18 Million CNY | -11.74% |
| 2010 Q2 | 120.31 Million CNY | 20.19% |
| 2010 FY | 516.22 Million CNY | 24.43% |
| 2010 Q1 | 100.1 Million CNY | 0.0% |
| 2010 Q4 | 189.62 Million CNY | 78.58% |
| 2009 FY | 414.88 Million CNY | 33.08% |
| 2008 FY | 311.75 Million CNY | 16.4% |
| 2007 FY | 267.83 Million CNY | 18.32% |
| 2006 FY | 226.37 Million CNY | 0.0% |